Menu

Comment on New NIH Center

Input lines are open for the National Institute of Substance Use and Addiction Disorders.

Feb 10, 2012
Megan Scudellari

NIH Campus

The National Institutes of Health is seeking input from the scientific community on the new National Institute of Substance Use and Addiction Disorders (working title), scheduled to open in 2014.

The proposed institute is the result of a November 2010 recommendation from the Scientific Management Review Board that the NIH should reorganize all substance use, abuse, and addiction-related research at the Institutes. Both the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism will be dissolved and their research programs folded into the new institute.

The NIH is asking for comments about “potential scientific opportunities and public health needs” that should be included in the new Institute’s strategic plan. Those comments can be submitted electronically, and will be accepted through May 11, 2012. The NIH will also conduct a series of public meetings to discuss the new Institute, which will be posted on the NIH’s feedback website.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.